Literature DB >> 15551031

[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].

A Ba-Ssalamah1, B Happel, J Kettenbach, A Dirisamer, F Wrba, F Längle, W Schima.   

Abstract

The liver is a common site for various benign and malignant focal lesions. The initial modality for assessing liver lesions is ultrasound or CT. MRI with its superior soft tissue contrast offers multiple advantages over other imaging modalities. Contrast agents have been developed that increase the detection rate and provide more specific information in comparison to unenhanced techniques. In the mean time three classes are available for MR imaging of the liver: extracellular gadolinium chelates, hepatobiliary and reticulo-endothelia, superparamagnetic agents. We describe in this review the most common focal lesions, their diagnostic possibilities, and the imaging protocols. Clinical use of these contrast agents facilitates detection and differential diagnosis of focal liver lesions that may help to avoid invasive procedures such as biopsy for lesion characterization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15551031     DOI: 10.1007/s00117-004-1142-5

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  38 in total

1.  Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases.

Authors:  G L Bennett; A Petersein; W W Mayo-Smith; P F Hahn; W Schima; S Saini
Journal:  AJR Am J Roentgenol       Date:  2000-02       Impact factor: 3.959

Review 2.  MR imaging of the liver using gadolinium chelates.

Authors:  R N Low
Journal:  Magn Reson Imaging Clin N Am       Date:  2001-11       Impact factor: 2.266

Review 3.  Imaging of benign liver lesions.

Authors:  D Mathieu; F Caseiro-Alves
Journal:  JBR-BTR       Date:  2004 Mar-Apr

4.  Liver pathology associated with the use of anabolic-androgenic steroids.

Authors:  K L Søe; M Søe; C Gluud
Journal:  Liver       Date:  1992-04

Review 5.  Management of metastatic cancer to the liver.

Authors:  P H Sugarbaker; N Kemeny
Journal:  Adv Surg       Date:  1989

Review 6.  Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.

Authors:  J K McLarney; P T Rucker; G N Bender; Z D Goodman; N Kashitani; P R Ros
Journal:  Radiographics       Date:  1999 Mar-Apr       Impact factor: 5.333

7.  Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.

Authors:  Thomas J Vogl; Wolfram Schwarz; Stefan Blume; Michael Pietsch; Kohkan Shamsi; Martina Franz; Hartmut Lobeck; Thomas Balzer; Kelly del Tredici; Peter Neuhaus; Roland Felix; Renate M Hammerstingl
Journal:  Eur Radiol       Date:  2002-09-10       Impact factor: 5.315

8.  Spectrum of MRI appearances of untreated metastases of the liver.

Authors:  Ioana-Maria Danet; Richard C Semelka; Polytimi Leonardou; Larissa Braga; Georgeta Vaidean; John T Woosley; Masayuki Kanematsu
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

9.  Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.

Authors:  S Worawattanakul; R C Semelka; T C Noone; B F Calvo; N L Kelekis; J T Woosley
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

Review 10.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

View more
  8 in total

Review 1.  [New developments in MRI of the liver].

Authors:  N Bastati-Huber; H Prosch; S Baroud; S Magnaldi; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

Review 2.  [Radiological diagnosis of primary hepatic malignancy].

Authors:  Benjamin Henninger; Johannes Petersen; Werner Jaschke
Journal:  Wien Med Wochenschr       Date:  2013-02-08

3.  Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue.

Authors:  Julia Greiser; Tobias Niksch; Wolfgang Weigand; Martin Freesmeyer
Journal:  J Vis Exp       Date:  2016-08-17       Impact factor: 1.355

Review 4.  [Benign focal hepatic lesions].

Authors:  S Baroud; N Bastati; H Prosch; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

5.  [Modern diagnostics of cystic liver lesions and hemangiomas].

Authors:  S Pötter-Lang; G Brancatelli; N Bastati-Huber; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-01       Impact factor: 0.635

Review 6.  [Optimized detection and characterization of liver metastases : The role of current MRI contrast agents].

Authors:  J M Weinrich; L Well; P Bannas
Journal:  Radiologe       Date:  2017-05       Impact factor: 0.635

Review 7.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

Review 8.  Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver.

Authors:  Julia Greiser; Wolfgang Weigand; Martin Freesmeyer
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.